Allegra-D 12 hour
Selected indexed studies
- OTC product: Zyrtec and Zyrtec-D 12 hour. (J Am Pharm Assoc (2003), 2008) [PMID:18359738]
- Multiple H1-antihistamine-induced urticaria. (J Dermatol, 2009) [PMID:19348661]
- The risk of esophageal obstruction associated with an anti-allergy medication (Claritin-D 24-Hour--original formulation). (Pharmacoepidemiol Drug Saf, 2004) [PMID:14971120]
_Worker-drafted node — pending editorial review._
Connections
Allegra-D 12 hour is a side effect of
Sources
- OTC product: Zyrtec and Zyrtec-D 12 hour. (2008) pubmed
- Multiple H1-antihistamine-induced urticaria. (2009) pubmed
- The risk of esophageal obstruction associated with an anti-allergy medication (Claritin-D 24-Hour--original formulation). (2004) pubmed
- Safety and tolerability of treatments for allergic rhinitis in children. (2004) pubmed
- Effect of fexofenadine hydrochloride on allergic rhinitis aggravated by air pollutants. (2021) pubmed
- Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis. (1998) pubmed
- Comparative nasal airflow with loratadine-pseudoephedrine and fluticasone nasal spray for allergic rhinitis. (2021) pubmed
- Clinical pharmacology of H1-antihistamines in the skin. (2002) pubmed
- Efficacy and safety of fexofenadine hydrochloride for treatment of seasonal allergic rhinitis. (1997) pubmed
- Limitations of fexofenadine limited sampling strategy using plasma concentrations and partial area under the concentration-time curve to estimate transporter activity in healthy adults. (2023) pubmed